Building attention and edge message passing neural networks for bioactivity and physical-chemical property prediction.

Deep learning Graph convolution Machine learning Message passing neural network Virtual screening

Journal

Journal of cheminformatics
ISSN: 1758-2946
Titre abrégé: J Cheminform
Pays: England
ID NLM: 101516718

Informations de publication

Date de publication:
08 Jan 2020
Historique:
received: 17 09 2019
accepted: 25 12 2019
entrez: 12 1 2021
pubmed: 13 1 2021
medline: 13 1 2021
Statut: epublish

Résumé

Neural Message Passing for graphs is a promising and relatively recent approach for applying Machine Learning to networked data. As molecules can be described intrinsically as a molecular graph, it makes sense to apply these techniques to improve molecular property prediction in the field of cheminformatics. We introduce Attention and Edge Memory schemes to the existing message passing neural network framework, and benchmark our approaches against eight different physical-chemical and bioactivity datasets from the literature. We remove the need to introduce a priori knowledge of the task and chemical descriptor calculation by using only fundamental graph-derived properties. Our results consistently perform on-par with other state-of-the-art machine learning approaches, and set a new standard on sparse multi-task virtual screening targets. We also investigate model performance as a function of dataset preprocessing, and make some suggestions regarding hyperparameter selection.

Identifiants

pubmed: 33430988
doi: 10.1186/s13321-019-0407-y
pii: 10.1186/s13321-019-0407-y
pmc: PMC6951016
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 676434

Références

J Comput Aided Mol Des. 2005 Sep-Oct;19(9-10):749-64
pubmed: 16267691
Nucleic Acids Res. 2016 Jan 4;44(D1):D1075-9
pubmed: 26481350
J Chem Inf Model. 2009 Feb;49(2):169-84
pubmed: 19434821
IEEE Trans Neural Netw. 2009 Jan;20(1):61-80
pubmed: 19068426
Chem Sci. 2017 Oct 31;9(2):513-530
pubmed: 29629118
Mol Pharm. 2014 Aug 4;11(8):2962-72
pubmed: 24919008
Nat Commun. 2017 Jan 09;8:13890
pubmed: 28067221
Mol Inform. 2019 Apr;38(4):e1800108
pubmed: 30499195
J Med Chem. 1996 Jul 19;39(15):2887-93
pubmed: 8709122
J Chem Inf Comput Sci. 2004 May-Jun;44(3):1000-5
pubmed: 15154768
J Comput Aided Mol Des. 2005 Sep-Oct;19(9-10):705-13
pubmed: 16267690
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
Adv Drug Deliv Rev. 2002 Mar 31;54(3):355-66
pubmed: 11922952
Blood. 1991 Oct 1;78(7):1722-9
pubmed: 1912562
J Mol Graph Model. 2007 Oct;26(3):622-33
pubmed: 17395510
Expert Opin Drug Discov. 2016 Aug;11(8):785-95
pubmed: 27295548
J Chem Inf Model. 2017 Aug 28;57(8):1757-1772
pubmed: 28696688
IEEE Trans Neural Netw. 2009 Mar;20(3):498-511
pubmed: 19193509
J Comput Aided Mol Des. 2005 Sep-Oct;19(9-10):625-35
pubmed: 16322910
J Chem Phys. 2015 Aug 28;143(8):084111
pubmed: 26328822
ACS Cent Sci. 2017 Apr 26;3(4):283-293
pubmed: 28470045
J Comput Aided Mol Des. 2016 Aug;30(8):595-608
pubmed: 27558503
J Chem Inf Model. 2012 Jun 25;52(6):1686-97
pubmed: 22612593
Drug Discov Today. 2018 Jun;23(6):1241-1250
pubmed: 29366762

Auteurs

M Withnall (M)

Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden. followup@withnall.org.uk.

E Lindelöf (E)

Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden. edvardlindelof@gmail.com.

O Engkvist (O)

Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

H Chen (H)

Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Centre of Chemistry and Chemical Biology, Guangzhou Regenerative Medicine and Health-Guangdong Laboratory, 190 Kai Yuan Avenue, Science Park, Guangzhou, China.

Classifications MeSH